Sinovac Biotech (SVA)
6.47
0.00 (0.00%)
Upcoming Events
Latest Headlines
Seraxis names ex-FDA officer as CMO ahead of Sernova merger
October 19, 2026 7:00 AM - StreetInsider
Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
October 19, 2026 7:00 AM - Globe NewsWire
Sernova and Seraxis close $11.2M financing ahead of merger
October 5, 2026 7:00 AM - StreetInsider
Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
October 5, 2026 7:00 AM - Globe NewsWire
Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference
September 25, 2026 7:00 AM - Globe NewsWire
Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference
September 10, 2026 7:00 AM - Globe NewsWire
Sernova and Seraxis agree to merge, forming BetaNova Biosciences
September 8, 2026 7:01 AM - StreetInsider
Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
September 8, 2026 7:00 AM - Globe NewsWire
Form 6-K SINOVAC BIOTECH LTD For: Aug 17
August 17, 2026 8:12 AM - SEC Filing
SINOVAC Reports Unaudited First Half of 2026 Financial Results
August 17, 2026 8:00 AM - BizWire
Full Article List
